Takahiro Tsujikawa

7.2k citations
54 papers · 1.3k indexed · 1 hit paper · h-index 18
Topics
Cancer Immunotherapy and Biomarkers (17 papers)Head and Neck Cancer Studies (8 papers)Cancer Cells and Metastasis (6 papers)
Journals
The Journal of Experimental MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations
JapanUnited StatesIndia

In The Last Decade

Takahiro Tsujikawa

50 papers receiving 1.3k citations

Hit Papers

Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk D...20152026201820222015100200300

Peers

Takahiro Tsujikawa
Comparison fields: 5 of 112
  • Oncology 720
  • Immunology 541
  • Molecular Biology 351
  • Pulmonary and Respiratory Medicine 144
  • Cancer Research 144
Replace Mehrdad Rakaee with:
Mehrdad Rakaee Norway
Maxime Meylan France
John Lövrot Sweden
Claire Smith United States
Guozhu Xie China
PR Carroll United States
Kazuo Koyanagi Japan
Shraddha A. Ravani United States
Shin‐ei Noda Japan
Ludivine Bochet France
Takahiro Tsujikawa relative to Mehrdad Rakaee Norway Mehrdad Rakaee's profile →
Citations per field
00.5×1.5×
Mehrdad Rakaee · 1×
Citations per year

Countries citing papers authored by Takahiro Tsujikawa

Since Specialization
Citations

This map shows the geographic impact of Takahiro Tsujikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiro Tsujikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiro Tsujikawa more than expected).

Fields of papers citing papers by Takahiro Tsujikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahiro Tsujikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiro Tsujikawa. The network helps show where Takahiro Tsujikawa may publish in the future.

Co-authorship network of co-authors of Takahiro Tsujikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Takahiro Tsujikawa. A scholar is included among the top collaborators of Takahiro Tsujikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahiro Tsujikawa. Takahiro Tsujikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 6
4 4
5 1
6 3
7 18
8 17
9 10
10 41
11 4
12 88
13 64
14 7
15 22
16 7
17 52
18
Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancerbreakdown →
381
19 44
20 0

About Takahiro Tsujikawa

Takahiro Tsujikawa is a scholar working on Otorhinolaryngology, Oncology and Immunology, having authored 54 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Head and Neck Cancer Studies (8 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Oncology (720 citations), Immunology (541 citations) and Cancer Research (144 citations). Takahiro Tsujikawa has collaborated with scholars based in Japan, United States and India. Frequent co-authors include Lisa M. Coussens, Shannon M. Liudahl, Brian Ruffell, Douglas Hanahan, Morgan Truitt, Betty Chang, Megan M. Kaneda, Nesrine I. Affara, Margaret A. Tempero and Brett C. Sheppard. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026